Case Study and Clinical Highlight: Diagnosis of Pulmonary Involvement in Systemic Sclerosis

Case Study and Clinical Highlight: Diagnosis of Pulmonary Involvement in Systemic Sclerosis

Engage in this case study to test your diagnostic ability to differentiate pulmonary hypertension in the setting of systemic sclerosis.

Latest News

On-Demand Sildenafil May Be Promising Second-Line Treatment for Raynaud Phenomenon

On-Demand Sildenafil May Be Promising Second-Line Treatment for Raynaud Phenomenon

Results did not show that on-demand sildenafil was more effective than placebo from a clinical standpoint.

Clinical Features Identified for Localized Scleroderma in Children

Clinical Features Identified for Localized Scleroderma in Children

Researchers conducted a multicenter prospective study to identify clinical features characteristic of localized scleroderma in children.

Depression Prevalent Among Individuals With Systemic Sclerosis

Depression Prevalent Among Individuals With Systemic Sclerosis

Depression is prevalent in a considerable proportion of patients with systemic sclerosis.

Statin Initiation Reduces Overall Mortality in Systemic Autoimmune Rheumatic Diseases

Statin Initiation Reduces Overall Mortality in Systemic Autoimmune Rheumatic Diseases

The initiation of statin therapy is associated with reduced overall mortality in patients with systemic autoimmune rheumatic diseases.

Ultrasonographic Synovial Involvement Frequent in Systemic Sclerosis

Ultrasonographic Synovial Involvement Frequent in Systemic Sclerosis

Ultrasonographic synovial involvement is frequent in patients with systemic sclerosis.

Gene Therapy for Localized Scleroderma Gets FDA's Fast Track Designation

Gene Therapy for Localized Scleroderma Gets FDA's Fast Track Designation

Clinical enrollment for an open-label, single-arm Phase 1/2 trial of FCX-013 was initiated in August 2018.

Rituximab Safe and Efficacious Alternative Treatment for Scleroderma

Rituximab Safe and Efficacious Alternative Treatment for Scleroderma

Rituximab is a safe and effective alternative to cyclophosphamide in managing the progression of scleroderma and subsequent development of interstitial lung disease.

Older Age Associated With Greater Cardiac Involvement in Early Systemic Sclerosis

Older Age Associated With Greater Cardiac Involvement in Early Systemic Sclerosis

In patients in the early stages of systemic sclerosis, older patients had more severe disease with greater cardiac involvement.

Risk Factors for Scleroderma Renal Crisis in Systemic Sclerosis

Risk Factors for Scleroderma Renal Crisis in Systemic Sclerosis

Researchers identify risk factors for scleroderma renal crisis in patients with systemic sclerosis.

Strong Reproducibility for 6-Minute Walk Test in Systemic Sclerosis

Strong Reproducibility for 6-Minute Walk Test in Systemic Sclerosis

Investigators assessed the reproducibility and the utility of the 6-minute walk test in systemic sclerosis.

Sign Up for Free e-newsletters